304 related articles for article (PubMed ID: 18787841)
1. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.
Weiner SJ; Neragi-Miandoab S
J Cancer Res Clin Oncol; 2009 Jan; 135(1):15-27. PubMed ID: 18787841
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors.
Weiner SJ; Neragi-Miandoab S
J Carcinog; 2008 Jul; 7():3. PubMed ID: 18662397
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of malignant pleural mesothelioma.
Jaurand MC; Fleury-Feith J
Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
[TBL] [Abstract][Full Text] [Related]
4. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
[TBL] [Abstract][Full Text] [Related]
5. Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres.
Proietti L; Spicuzza L; Di Maria A; Polosa R; Sebastian Torres E; Asero V; Di Maria GU
Monaldi Arch Chest Dis; 2006 Dec; 65(4):210-6. PubMed ID: 17393666
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Signatures in Malignant Pleural Mesothelioma Effusions.
Birnie KA; Prêle CM; Musk AWB; de Klerk N; Lee YCG; Fitzgerald D; Allcock RJN; Thompson PJ; Creaney J; Badrian B; Mutsaers SE
Dis Markers; 2019; 2019():8628612. PubMed ID: 31481984
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos.
Okten F; Köksal D; Onal M; Ozcan A; Simşek C; Ertürk H
Clin Imaging; 2006; 30(3):177-80. PubMed ID: 16632152
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40.
Gazdar AF; Carbone M
Clin Lung Cancer; 2003 Nov; 5(3):177-81. PubMed ID: 14667274
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor, a new soluble biomarker for malignant pleural mesothelioma involved in angiogenesis.
Smeele P; d'Almeida SM; Meiller C; Chéné AL; Liddell C; Cellerin L; Montagne F; Deshayes S; Benziane S; Copin MC; Hofman P; Le Pimpec-Barthes F; Porte H; Scherpereel A; Grégoire M; Jean D; Blanquart C
Mol Cancer; 2018 Oct; 17(1):148. PubMed ID: 30309369
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma.
Ho L; Sugarbaker DJ; Skarin AT
Cancer Treat Res; 2001; 105():327-73. PubMed ID: 11224994
[TBL] [Abstract][Full Text] [Related]
11. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
[TBL] [Abstract][Full Text] [Related]
12. Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Nakajima Y; Kuribayashi K; Ishigaki H; Tada A; Negi Y; Minami T; Takahashi R; Doi H; Kitajima K; Yokoi T; Kijima T
Cancer Invest; 2020 Jul; 38(6):356-364. PubMed ID: 32468861
[TBL] [Abstract][Full Text] [Related]
13. Sister chromatid exchange rate from pleural fluid cells in patients with malignant mesothelioma.
Atalay F; Baltaci V; Alpas I; Savas I; Atikcan S; Balci S
Mutat Res; 2000 Feb; 465(1-2):159-63. PubMed ID: 10708982
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases.
Senyiğit A; Bayram H; Babayiğit C; Topçu F; Balci AE; Satici O
Respiration; 2000; 67(6):623-9. PubMed ID: 11124644
[TBL] [Abstract][Full Text] [Related]
15. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey.
Emri S; Kocagoz T; Olut A; Güngen Y; Mutti L; Baris YI
Anticancer Res; 2000; 20(2A):891-4. PubMed ID: 10810372
[TBL] [Abstract][Full Text] [Related]
16. The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review.
Congedo MT; West EC; Evangelista J; Mattingly AA; Calabrese G; Sassorossi C; Nocera A; Chiappetta M; Flamini S; Abenavoli L; Margaritora S; Boccuto L; Lococo F
J Thorac Dis; 2024 Jan; 16(1):671-687. PubMed ID: 38410609
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
Neri M; Ugolini D; Dianzani I; Gemignani F; Landi S; Cesario A; Magnani C; Mutti L; Puntoni R; Bonassi S
Mutat Res; 2008; 659(1-2):126-36. PubMed ID: 18420450
[TBL] [Abstract][Full Text] [Related]
18. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic features of erionite-induced malignant mesothelioma.
Demirer E; Ghattas CF; Radwan MO; Elamin EM
Yonsei Med J; 2015 Mar; 56(2):311-23. PubMed ID: 25683976
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.
Battolla E; Canessa PA; Ferro P; Franceschini MC; Fontana V; Dessanti P; Pinelli V; Morabito A; Fedeli F; Pistillo MP; Roncella S
Anticancer Res; 2017 Mar; 37(3):1387-1391. PubMed ID: 28314308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
